help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 15, 2007
Endocrinology, doi:10.1210/en.2007-1234
A more recent version of this article appeared on February 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/2/725    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Laan, S.
Right arrow Articles by Meijer, O. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Laan, S.
Right arrow Articles by Meijer, O. C.

Submitted on September 6, 2007
Accepted on November 8, 2007

Nuclear receptor coregulators differentially modulate CREB-mediated induction and glucocorticoid receptor mediated repression of the CRH gene

S. van der Laan*, S. B. Lachize, E. Vreugendhil, E. R. de Kloet, and O. C. Meijer

Division of Medical Pharmacology, Leiden/Amsterdam Centre for Drug Research and Leiden University Medical Centre, PO Box 9502, 2300 RA Leiden, The Netherlands

* To whom correspondence should be addressed. E-mail: s.van.der.laan{at}lacdr.leidenuniv.nl.

Nuclear receptor coregulators are proteins that modulate the transcriptional activity of steroid receptors, and may explain cell specific effects of glucocorticoid receptor action. Based on the uneven distribution of a number of coregulators in corticotropin-releasing hormone (CRH) expressing cells in the hypothalamus of the rat brain, we tested the hypothesis that these proteins are involved as mediators in the glucocorticoid induced repression of the CRH promoter. Therefore, we have assessed the role of the steroid receptor coactivator 1a (SRC1a), SRC-1e, and corepressors N-CoR and SMRT on both induction and repression of CRH in the AtT-20 cell-line, a model system for CRH repression by glucocorticoids. We show that the concentration of glucocorticoid receptor and the type of ligand, i.e. corticosterone or dexamethasone, determines the repression. Furthermore, overexpression of SRC1a, but not SRC1e, increased both efficacy and potency of the glucocorticoid receptor mediated repression of the forskolin-induced CRH promoter. Unexpectedly, co-transfection of the corepressors N-CoR and SMRT did not affect the corticosterone-dependent repression, but resulted in a marked decrease of the forskolin stimulation of the CRH gene. Altogether, our data demonstrate that 1) the concentration of the receptor, 2) the type of ligand and 3) the coregulator recruited, all determine the expression and the repression of the CRH gene. We conclude that modulation of coregulator activity may play a role in the control of the hypothalamus-pituitary-adrenal axis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society